Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 528 participants.

Also called NCT05257824

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 528 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05257824
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05257824. Randomized; no masking; primary purpose treatment. Start 2022-06-23 (actual); primary completion 2025-12-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
Condition
Aneurysm Cerebral
Condition
Endovascular Procedures
Intervention (Drug)
Aspirin 100mg
Intervention (Drug)
Clopidogrel 75mg
Lead sponsor
Seoul National University Bundang Hospital (class: other)
Collaborator
Pusan National University Yangsan Hospital (class: other)
Collaborator
Keimyung University Dongsan Medical Center (class: other)
Collaborator
Uijeongbu St. Mary's Hospital (class: not stated)
Collaborator
Chungnam National University Sejong Hospital (class: other)
Collaborator
Soonchunhyang University Hospital (class: other)
Collaborator
Asan Medical Center (class: other)
Collaborator
Gangnam Severance Hospital, Yonsei University College of Medicine (class: not stated)

Record details

Record id
cardio:ct-nct05257824
Content hash
9704d31085aed916dc1c8610e75261804c03ddda2e30465f010723da2f9f46c0